Search research articles
Contact Us
Filters
Showing results (251-260 of 292) with videos related to
Page
of 30
Sort By:
Cancer
|
November 20, 2023
Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study
Max J Gordon, Lei Feng, Paolo Strati, et al.
British Journal of Cancer
|
June 29, 2022
Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk
Mathilde M Almekinders, Tycho Bismeijer, Tapsi Kumar, et al.
Nature Medicine
|
November 14, 2018
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
Yinghong Wang, Diana H Wiesnoski, Beth A Helmink, et al.
Cell Reports
|
May 25, 2017
Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors
Maithili P Dalvi, Lei Wang, Rui Zhong, et al.
The Lancet. Oncology
|
September 27, 2020
Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial
Mariano Provencio, Ernest Nadal, Amelia Insa, et al.
Nature Medicine
|
November 28, 2018
Author Correction: Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
Yinghong Wang, Diana H Wiesnoski, Beth A Helmink, et al.
Cell Reports. Medicine
|
August 16, 2023
Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNγ-expressing CD8 T cells
Paolo Strati, Xubin Li, Qing Deng, et al.
Journal for Immunotherapy of Cancer
|
October 20, 2024
Perioperative chemoimmunotherapy induces strong immune responses and long-term survival in patients with HLA class I-deficient non-small cell lung cancer
Marta Molina-Alejandre, Francisco Perea, Virginia Calvo, et al.
Nature Communications
|
April 27, 2025
Improved overall survival in an anti-PD-L1 treated cohort of newly diagnosed glioblastoma patients is associated with distinct immune, mutation, and gut microbiome features: a single arm prospective phase I/II trial
Shiao-Pei Weathers, Xiqi Li, Haifeng Zhu, et al.
Cancer Discovery
|
September 13, 2022
The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma
Dapeng Hao, Guangchun Han, Ansam Sinjab, et al.
Page
of 30
Search research articles
Search
Showing results (251-260 of 292) with videos related to
Sort By:
Page
of 30
Cancer
|
November 20, 2023
Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study
Max J Gordon, Lei Feng, Paolo Strati, et al.
British Journal of Cancer
|
June 29, 2022
Comprehensive multiplexed immune profiling of the ductal carcinoma in situ immune microenvironment regarding subsequent ipsilateral invasive breast cancer risk
Mathilde M Almekinders, Tycho Bismeijer, Tapsi Kumar, et al.
Nature Medicine
|
November 14, 2018
Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
Yinghong Wang, Diana H Wiesnoski, Beth A Helmink, et al.
Cell Reports
|
May 25, 2017
Taxane-Platin-Resistant Lung Cancers Co-develop Hypersensitivity to JumonjiC Demethylase Inhibitors
Maithili P Dalvi, Lei Wang, Rui Zhong, et al.
The Lancet. Oncology
|
September 27, 2020
Neoadjuvant chemotherapy and nivolumab in resectable non-small-cell lung cancer (NADIM): an open-label, multicentre, single-arm, phase 2 trial
Mariano Provencio, Ernest Nadal, Amelia Insa, et al.
Nature Medicine
|
November 28, 2018
Author Correction: Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis
Yinghong Wang, Diana H Wiesnoski, Beth A Helmink, et al.
Cell Reports. Medicine
|
August 16, 2023
Prolonged cytopenia following CD19 CAR T cell therapy is linked with bone marrow infiltration of clonally expanded IFNγ-expressing CD8 T cells
Paolo Strati, Xubin Li, Qing Deng, et al.
Journal for Immunotherapy of Cancer
|
October 20, 2024
Perioperative chemoimmunotherapy induces strong immune responses and long-term survival in patients with HLA class I-deficient non-small cell lung cancer
Marta Molina-Alejandre, Francisco Perea, Virginia Calvo, et al.
Nature Communications
|
April 27, 2025
Improved overall survival in an anti-PD-L1 treated cohort of newly diagnosed glioblastoma patients is associated with distinct immune, mutation, and gut microbiome features: a single arm prospective phase I/II trial
Shiao-Pei Weathers, Xiqi Li, Haifeng Zhu, et al.
Cancer Discovery
|
September 13, 2022
The Single-Cell Immunogenomic Landscape of B and Plasma Cells in Early-Stage Lung Adenocarcinoma
Dapeng Hao, Guangchun Han, Ansam Sinjab, et al.
Page
of 30